FUSHIMI Pharmaceutical

Fushimi Pharmaceutical is a Japanese pharmaceutical company headquartered in Marugame, Kagawa, specializing in the development and manufacture of gastrointestinal medications, contrast agents, and oral care products. Founded in 1923, the company is widely recognized for its Barytgen line of barium sulfate contrast media used in X-ray examinations. In addition to its own product portfolio, Fushimi operates as a contract development and manufacturing organization (CDMO), providing synthesis and formulation services for various chemical and pharmaceutical applications. Their oral care brand, ConCool, is a leader in the Japanese dental market for preventing periodontal disease and tooth decay. The company maintains a strong focus on quality control and manufacturing excellence within the Japanese domestic market.